Clinical trial

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With…

NCT00465725 · Poniard Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00465725
Title A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
Official title A Randomized Crossover Oral Bioavailability Study Comparing the Pharmacokinetics and Pharmacodynamics of Picoplatin Administered Orally With Picoplatin Administered Intravenously in Subjects With Advanced Non-Hematological Malignancies
Lead sponsor Poniard Pharmaceuticals, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastrointestinal Neoplasm, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer
Intervention type Drug
Interventions Picoplatin
Enrollment 18
Start date Apr 1, 2007
Primary completion Jul 1, 2009
Completion Jul 1, 2009
First posted Apr 25, 2007
Last update posted Sep 24, 2009
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies